Findings

What do systematic reviews say?

24 questions · 24 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4 · 16.7%GRADE not reported 1 · 4.2%Very low 5 · 20.8%Low 9 · 37.5%Moderate 5 · 20.8%High 0 · 0%

Minoxidil 2% vs minoxidil 5%

Change in quality of life · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 209 participants
Low

Minoxidil 2% vs minoxidil 5%

Adverse events · women with FPHL

Minoxidil 2% showed no clear difference in adverse events compared with minoxidil 5% (low certainty).

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
RR 1.02 [0.91, 1.2]
4 studies · 1006 participants
Low

Minoxidil 2% vs minoxidil 5%

Proportion of participants with investigator‐rated clinically significant hair regrowth · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 586 participants
Moderate

Minoxidil 2% vs minoxidil 5%

Change from baseline to study conclusion in total hair count · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 631 participants
Low

Minoxidil 2% vs minoxidil 5%

Degree of hair shedding from baseline to the end of the study · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Minoxidil 2% vs minoxidil 5%

Cosmetic appearance of the hair or participant satisfaction · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 322 participants
Moderate

Minoxidil 2% vs minoxidil 5%

Change in quality (or pattern) of hair regrowth (e.g. thickness) · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 322 participants
Moderate

Minoxidil 2% vs minoxidil 5%

Proportion of participants with self‐rated clinically significant hair regrowth · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 322 participants
Low

Minoxidil vs placebo

Proportion of participants with self‐rated clinically significant hair regrowth · women with FPHL

Minoxidil probably leads to higher the proportion of participants with self‐rated clinically… compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
RR 1.93 [1.51, 2.47]
6 studies · 1148 participants
Moderate

Minoxidil vs placebo

Change in quality of life · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
Low

Minoxidil vs placebo

Adverse events · women with FPHL

Minoxidil showed no clear difference in adverse events compared with placebo (low certainty).

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
RR 1.24 [0.82, 1.87]
4 studies · 727 participants
Low

Minoxidil vs placebo

Proportion of participants with investigator‐rated clinically significant hair regrowth · women with FPHL

Minoxidil probably leads to higher proportion of participants with investigator‐rated clinically… compared with placebo (moderate certainty).

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
RR 2.35 [1.68, 3.28]
7 studies · 1181 participants
Moderate

Minoxidil vs placebo

Change from baseline to study conclusion in total hair count · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1242 participants
Low

Minoxidil vs placebo

Degree of hair shedding from baseline to the end of the study · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 380 participants
Very low

Minoxidil vs placebo

Cosmetic appearance of the hair or participant satisfaction · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 260 participants
Low

Minoxidil vs placebo

Change in quality (or pattern) of hair regrowth (e.g. thickness) · women with FPHL

1 finding from 1 review

Interventions for female pattern hair loss 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 372 participants
Low

Minoxidil vs placebo

Short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of · adults with alopecia areata

It is very uncertain whether summary of findings table ‐ Topical hair growth stimulants (minoxidil) changes short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (very low certainty).

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
RR 2.31 [1.34, 3.96]
2 studies · 202 participants
Very low

Minoxidil vs placebo

Incidence of serious adverse events · adults with alopecia areata

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 304 participants
Very low

Minoxidil vs placebo

Health‐related quality of life ‐ not reported · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Minoxidil vs placebo

Long‐term hair regrowth ≥ 75% (greater than 26 weeks of · adults with alopecia areata

The review found no eligible studies for this question.

1 finding from 1 review

Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found